Minimally invasive treatment of hemangioma

Minimally invasive technology is a new method of treating tumors and other diseases that has emerged with the advancement of science and technology. Minimally invasive treatment of hemangiomas is also a common method in hospitals today. Firstly, because it is a minimally invasive technique, there is almost no pain, which reduces some of the pain and psychological burden on patients. Furthermore, this type of technology is not very expensive compared to interventional therapy, so it is very popular.

1. This technology uses ultrasound positioning to insert a microcatheter into the diseased blood vessels and enlarged areas that cause abnormal structures, and uses ultrasonic ablation technology inside the hemangioma to shrink the walls of the blood supply branches and narrow the lumen, reduce blood supply to the tumor, and achieve a balance between blood supply and return to the tumor, thereby achieving the purpose of cure.

2. Ultrasound micro-mediated technology is a new technology developed on the basis of interventional therapy and arteriovenous catheter technology. It is not as painful as interventional therapy and is not expensive. It is mainly used to treat cavernous hemangioma, lymphatic hemangioma, etc., and is particularly effective for hemangioma in infants and young children. Compared with other technologies: no radiation is generated, no radioactive substances are contained; no hormones, isotopes or chemotherapy drugs are used. It can also treat visceral hemangiomas (except intracranial and spinal cord hemangiomas) under three-dimensional positioning. This technology is suitable for a wide range of people. Generally, infants over one month old can be treated. However, people with highly sensitive constitutions, hemophilia, and leukemia are contraindicated.

3. Ultrasound micro-mediated technology generally requires 1 to 2 courses of treatment for hemangiomas, and each course requires 3-5 times. The number of treatments for particularly large hemangiomas will increase accordingly. This technology does not require anesthesia and can be used on infants and young children shortly after birth. No bleeding, no pain after treatment, no scars, and no possibility of deformity. There is no recurrence after cure and no toxic effects. After treatment, you need to stay in the hospital for observation for about 3-7 days.

4. Hemangioma is a benign tumor and generally does not affect health. If it is located on the body surface and affects the appearance, it can be removed through minimally invasive surgery. It is best to go to the surgery department of a regular hospital for standardized surgery.

5. Minimally invasive mediated therapy technology for the treatment of hemangioma is a new development in ultrasound medical technology. Hemangioma is treated with minimally invasive mediated surgery guided by color ultrasound. It is recommended to go to the hospital for further examination to clarify the cause of the disease and condition, and give targeted treatment under the guidance of a doctor.

6. Hemangioma is a congenital disease that develops from residual mesoderm tissue to form active endothelial-like germs that invade adjacent tissues to form endothelial-like cords, which are then tubularized and connected to the remaining blood vessels to form hemangiomas. The blood vessels within the tumor form a self-contained system that is not connected to the surrounding blood vessels. It is recommended that this disease or other diseases be treated as early as possible to prevent and control the development of the disease.